Constitutive expression of Interleukin‐18 and Interleukin‐18 receptor mRNA in tumour derived human B‐cell lines
Author(s) -
LOREY S. L.,
HUANG Y. C.,
SHARMA V.
Publication year - 2004
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/j.1365-2249.2004.02465.x
Subject(s) - biology , paracrine signalling , cytokine , secretion , immune system , messenger rna , receptor , interleukin , autocrine signalling , microbiology and biotechnology , interleukin 33 , cell culture , interleukin 15 , beta (programming language) , interleukin 4 receptor , immunology , gene , endocrinology , genetics , computer science , programming language
SUMMARY Interleukin‐18 (IL‐18) is a pro‐inflammatory cytokine involved in the Th1 immune response and expressed by a variety of cell types. IL‐18 is a member of the IL‐1 family and plays an important role in autoimmune diseases and inflammation. Using reverse transcriptase‐polymerase chain reaction (RT‐PCR) mRNA expression of IL‐18, IL‐18 receptor alpha (IL‐18R α ), and beta (IL‐18R β ) were studied in tumour derived human B‐cell lines. Furthermore, we investigated IL‐18 protein secretion by using enzyme linked immunosorbent assay (ELISA). The results, as presented in this report, suggest that IL‐18, IL‐18R α , and IL‐18R β mRNA are constitutively and ubiquitously expressed in human B‐cell lines, but secretion of the functional protein does not occur. We therefore speculate that IL‐18 possibly affects B‐cells through paracrine actions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom